11-64307375-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004451.5(ESRRA):c.196G>A(p.Gly66Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000374 in 1,604,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004451.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESRRA | NM_004451.5 | c.196G>A | p.Gly66Ser | missense_variant | 2/7 | ENST00000000442.11 | NP_004442.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESRRA | ENST00000000442.11 | c.196G>A | p.Gly66Ser | missense_variant | 2/7 | 1 | NM_004451.5 | ENSP00000000442 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000417 AC: 10AN: 239630Hom.: 0 AF XY: 0.0000382 AC XY: 5AN XY: 130876
GnomAD4 exome AF: 0.0000379 AC: 55AN: 1452490Hom.: 0 Cov.: 31 AF XY: 0.0000333 AC XY: 24AN XY: 721260
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152372Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.196G>A (p.G66S) alteration is located in exon 2 (coding exon 1) of the ESRRA gene. This alteration results from a G to A substitution at nucleotide position 196, causing the glycine (G) at amino acid position 66 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at